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Mutations in the filamin A (FlnA) gene are frequently
associated with severe arterial abnormalities,
although the physiological role for this cytoskeletal
element remains poorly understood in vascular
cells. We used a conditional mouse model to selec-
tively delete FlnA in smooth muscle (sm) cells at the
adult stage, thus avoiding the developmental ef-
fects of the knockout. Basal blood pressure
was significantly reduced in conscious smFlnA
knockout mice. Remarkably, pressure-dependent
tone of the resistance caudal artery was lost,
whereas reactivity to vasoconstrictors was pre-
served. Impairment of the myogenic behavior was
correlated with a lack of calcium influx in arterial
myocytes upon an increase in intraluminal pres-
sure. Notably, the stretch activation of CaV1.2
was blunted in the absence of smFlnA. In conclu-
sion, FlnA is a critical upstream element of the
signaling cascade underlying the myogenic tone.
These findings allow a better understanding of the
molecular basis of arterial autoregulation and asso-
ciated disease states.
INTRODUCTION
Filamin A (FlnA) is a cytoskeletal protein forming elongated
V-shaped dimers through association of its C-terminal domain
(Nakamura et al., 2011; Razinia et al., 2012). FlnA molecules
bind to actin through the N-terminal domain and thereby orthog-
onally cross-link actin filaments. Moreover, FlnA acts as a versa-
tile scaffold for numerous protein partners (Nakamura et al.,
2011; Razinia et al., 2012). Notably, FlnA links the actin cytoskel-
eton to the plasma membrane by interacting with several trans-2050 Cell Reports 14, 2050–2058, March 8, 2016 ª2016 The Authorsmembrane proteins, including membrane receptors, adhesion
molecules, and ion channels (Ehrlicher et al., 2011; Nakamura
et al., 2011; Razinia et al., 2012).
Null mutations in the X-linked FlnA gene are associated with a
remarkably large variety of symptoms (Reinstein et al., 2013;
Robertson, 2005). Hemizygosity leads in the majority of the
cases to embryonic lethality in males. In heterozygous females
carrying null FlnA mutations, periventricular nodular heterotopia
(PH) results from abnormal neuronal migration from the periven-
tricular region to the cortical area, causing epileptic seizures
(Robertson, 2005). Moreover, PH patients have a propensity
for aortic dilatation, aneurysms, abnormalities of the microcircu-
lation, premature stroke, and patent ductus arteriosus (Reinstein
et al., 2013; Robertson, 2005; Zhou et al., 2007). In addition, FlnA
missense mutations are linked to myxomatous valvular dystro-
phy and to otopalatodigital spectrum disorders (Robertson,
2005).
In line with the clinical observations, constitutive inactivation of
FlnA in mice causes embryonic lethality associated with blood
vessel leakage, further suggesting an important role for this cyto-
skeletal protein in the vasculature, at least during early develop-
ment (Feng et al., 2006; Hart et al., 2006). Although the role for
FlnA in neuronal migration has been extensively studied, its spe-
cific function in other cell types including arterial myocytes re-
mains elusive.
Recently, we demonstrated that FlnA regulates Piezo1
stretch-activated ion channels (SACs) in arterial myocytes
(Retailleau et al., 2015). Absence of smooth muscle FlnA
(smFlnA) greatly enhances the opening of SACs in response
to pressure stimulation, indicating that this cytoskeletal
element exerts a potent mechanoprotection over Piezo1.
smPiezo1 deletion does not alter the arterial myogenic
response, although it influences the hypertension-dependent
structural remodeling of resistance arteries in a major way (Re-
tailleau et al., 2015).
In the present report, using a conditional smooth-muscle-spe-
cific FlnA knockout mouse model (Retailleau et al., 2015), we
investigated the physiological role of this important cytoskeletal
element in small arteries at the adult stage.We show that smFlnA
is critically required for the myogenic response of small arteries
but is dispensable for reactivity to vasoconstrictors.
RESULTS
Smooth-Muscle-Specific and Conditional FlnA
Knockout Mouse Model
Given that FlnA constitutive inactivation is embryonic lethal
(Feng et al., 2006; Hart et al., 2006), we used a tamoxifen-
inducible conditional smMHC Cre* system to specifically
delete FlnA in smooth muscle cells (smFlnA0/) of adult male
mice, which are hemizygotic for FlnA (FlnA0/+) (Figure 1). Two
consecutive injections of tamoxifen (1 mg) resulted in a robust
knockout of FlnA, as determined by qPCR in de-endothelized
caudal cutaneous resistance arteries, at 2 weeks post-TAM in-
jection and without compensation by FlnB or FlnC (Figure 1A).
These findings were confirmed at the protein level by western
blotting using a monoclonal antibody directed against the
N-terminal domain of FlnA (Figure 1B). The band migrating at
about 190 kDa represents a cleaved form of FlnA, presumably
by calpain (Gorlin et al., 1990). The turnover of smFlnA was
remarkably slow and a period of 12 weeks after TAM induction
was required to achieve a complete deletion of the protein
(Figure 1C). FlnA, as well as a, b, and g smooth muscle actin
isoforms visualized by confocal microscopy in isolated myo-
cytes from the caudal artery were co-localized at the cell pe-
riphery (Figure 1D). In myocytes from smFlnA0/ mice, FlnA
expression was absent without an obvious change in the dis-
tribution of actin isoforms (Figure 1E), as previously reported
for the constitutive FlnA knockout mice (Feng et al., 2006;
Hart et al., 2006).
These data indicate that the smMHC Cre* system allows a
robust inactivation of FlnA in arterial myocytes, without lethality
or change in mouse body weight and size, at least 12 weeks
post-TAM induction (Figures S1A and S1B). Thus, this
conditional mousemodel allows the study of FlnA in the adult cir-
culation, without any influence of the developmental effects
associated with its knockout. Next, we examined the effect of
smFlnA deletion on blood pressure regulation in awoke mice fol-
lowed by telemetry measurements.
Deletion of smFlnA Lowers Systemic Blood Pressure
Arterial blood pressure was monitored in conscious mice using
telemetry (Figures S1C–S1F). Notably, basal blood pressure
was significantly reduced in the knockout animals, with a domi-
nant effect on systolic blood pressure, both during day and night
times (Figures S1D and S1F). Consequently, pulse pressure (the
difference between systolic and diastolic pressure) was lowered
by about 10 mm Hg in the absence of smFlnA. Upon infusion of
angiotensin II (Ang II), a strong hypertensive effect was observed
with a normalization of both diastolic and systolic pressure (Fig-
ures S1C–S1F).
Thus, smFlnA deletion lowers basal arterial pressure, but
without affecting reactivity to Ang II. Next, we investigated
whether this hypotensive effect might be linked to a change in
the basal tone of the resistance arteries.CesmFlnA Is Critically Required for the Caudal Artery
Myogenic Tone
Raising intraluminal pressure resulted in a maintained vasocon-
striction of the isolated caudal artery, a model of cutaneous
resistance artery (Figures 2A–2C, S1G, and S1H). Prominent
vasomotionwas also visible on top of themyogenic tone (Figures
2D–2F, S1G, and S1H). Both the myogenic response and vaso-
motion were observed in de-endothelized caudal arteries (n = 3),
required extracellular calcium, and were potently inhibited by
nifedipine (n = 3), confirming a central role for the L-type
voltage-dependent calcium channel CaV1.2 in the myogenic
response (Figures S1G and S1H) (Moosmang et al., 2003). Of
note, the AT1R antagonist losartan (10 mM) did not significantly
affect myogenic tone or vasomotion of the caudal artery (n = 6;
data not shown).
smFlnA deletion dramatically reduced the amplitude of the
caudal artery myogenic response, and the effect was graded in
time after TAM induction (Figures 2A–2C). At 2 weeks post-
TAM, no effect of the knockout was visible (Figure 2A). At
6 weeks, the myogenic response was only reduced above
100 mm Hg, while at 12 weeks post-TAM, the myogenic
response was impaired over the whole pressure range (Figures
2B and 2C). In addition, the amplitude of vasomotion was
reduced in the absence of smFlnA, with a significant effect
seen at both 6 and 12 weeks post-TAM (Figures 2E and 2F).
The myogenic tone in the absence of smFlnA was not rescued
by the addition of either 200 nM iberiotoxin or 100 mM
L-NAME, thus ruling out the involvement of BK channels or nitric
oxide in this phenotype (n = 3; data not shown). In the absence of
extracellular calcium and in the presence of sodium nitroprus-
side (SNP) and papaverine, the active myogenic response was
fully suppressed and passive inner diameter was determined at
increasing intraluminal pressure values (Figures S1I–S1K). A sig-
nificant inward remodeling of the caudal artery was observed,
but only at 12 weeks post-TAM induction (Figure S1K). Of
note, myogenic tone and vasomotion were already significantly
blunted at 6 weeks post-TAM induction, while passive diameter
was not yet modified (Figures 2B, 2E, and S1J).
Thus, smooth muscle FlnA deletion strongly impairs the
myogenic behavior of the caudal artery. Next, we investigated
whether smFlnA deletion might similarly affect reactivity to
various vasoactive agents.
Reactivity of the Caudal Artery to Vasoconstrictors Is
Preserved in the Absence of Smooth Muscle FlnA
We used isometric myography to test whether vasoconstriction
in response to agonists might be altered in the absence of
smFlnA (Figure S2). Reactivity to vasoconstrictors was mostly
preserved upon smFlnA deletion, despite a mild decrease in
the contractile response to KCl (80 mM) (Figures S2A–S2C). In
addition, endothelium-dependent vasorelaxation in response
to acetylcholine was unaltered by smFlnA inactivation
(Figure S2D).
These findings demonstrate that smFlnA deletion predomi-
nantly impairs the myogenic tone of the caudal artery, without
affecting reactivity to receptor agonists. Cross-linking of muscle
actin filaments by low concentrations of FlnA reduces the con-
centration of myosin required for contraction of actin (Stendahlll Reports 14, 2050–2058, March 8, 2016 ª2016 The Authors 2051
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Figure 1. Smooth-Muscle-Cell-Specific and Conditional Knockout of FlnA
(A) qPCR data demonstrating the loss of FlnA mRNA in de-endothelized caudal artery segments from smFlnA0/+ (white bars) or smFlnA0/ (black bars) mice at
2 weeks post-TAM induction. FlnB and FlnC expression is low in de-endothelized caudal arteries of either smFlnA0/+ or smFlnA0/ mice.
(B) Western blot demonstrating a dramatic decrease in FlnA protein expression (top bands) in de-endothelized caudal arteries from smFlnA0/, as compared to
smFlnA0/+ mice at 12 weeks post-TAM induction. The lower band shows calnexin expression, as a loading control.
(C) FlnA protein expression in de-endothelized caudal arteries, as function of time after TAM induction.
(D) Co-localization of FlnAwith actin isoforms (a, b, and g) in enzymatically dispersedmyocytes from smFlnA0/+ caudal arteries. The inset shows amagnification of
the boxed region.
(E) FlnA is absent in myocytes from smFlnA0/ caudal arteries induced by TAM for 12 weeks. The inset shows a magnification of the boxed region. Nuclei are
shown in blue, FlnA is shown in red (left panels), and actin is shown in green (middle panels) and the merged images (right panels).
Data are shown as means ± SEM.
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AD E F
B C Figure 2. Myogenic Tone and Vasomotion of
the Caudal Artery Are Dramatically Impaired
in the Absence of smFlnA
(A) Myogenic tone (MT), expressed as a percent-
age of passive arterial diameter (PD) measured in
isolated caudal artery segments of smFlnA0/+
(white circles) and smFlnA0/ (black circles) mice
as a function of intraluminal pressure at 2 weeks
post-TAM induction.
(B) At 6 weeks post-TAM induction.
(C) At 12 weeks post-TAM induction.
(D) Vasomotion (VM), expressed as a percentage
of passive arterial diameter measured in isolated
caudal artery segments of smFlnA0/+ (white circles)
and smFlnA0/ (black circles) mice, as a function of
intraluminal pressure at 2 weeks post-TAM in-
duction.
(E) At 6 weeks post-TAM induction.
(F) At 12 weeks post-TAM induction. Two arterial
segments per mouse were tested and the number
of mice (N) is indicated.
Data are shown as means ± SEM.and Stossel, 1980). Moreover, FlnA decreases the inhibitory ac-
tion of caldesmon on actin-activated myosin ATPase and poten-
tiates the reversal of this inhibition by calmodulin (Gusev et al.,
1994). Thus, deletion of smFlnA is anticipated to impact on the
general contractile properties of the arteries, as demonstrated
by the modest reduction in the KCl-mediated vasoconstriction.
However, the loss in myogenic tone was much more prominent
and rather indicates a specific defect in smooth muscle mecha-
notransduction upon smFlnA deletion. Next, we investigated
whether the renal circulation, another vascular bed character-
ized by a potent autoregulation, might be similarly altered upon
smFlnA deletion (Carlstro¨m et al., 2015).
Basal Resistance of the Renal Circulation Is Dependent
on smFlnA
In isolated kidneys, stepwise increase in arterial perfusion flow
rate induced a progressive active increase in perfusion pressure
(Figures S3A and S3D). Removal of extracellular calcium and
addition of SNP fully suppressed this active response (Fig-
ure S3D, in red). Notably, the passive response in the absence
of extracellular calcium together with SNP was similar between
both mouse lines (Figure S3D, in red). The difference between
the perfusion pressure in the presence and in the absence of cal-
cium added with SNP represents the active tone (Figures S3A
and S3D). Remarkably, the active increase in resistance of the
renal circulation in the higher flow rangewas significantly blunted
in the smFlnA0/ mice (Figures S3A and S3D, black dots). By
contrast, Ang II- and PE-mediated vasoconstrictions as well as
endothelium-dependent renal artery dilatation induced by ACh
were not significantly affected by deletion of smFlnA (Figures
S3E–S3G).
In line with these ex vivo findings, the myogenic tone of iso-
lated third-order intra-renal arteries measured by isobaric arteri-
ography in vitro was lost in the absence of smFlnA at 12 weeks
post-TAM induction (Figure S3B). Again, reactivity to Ang IICe(normalization to the KCl response) was preserved, despite a
mild decrease in the KCl response, as previously observed for
the caudal artery (Figures S3H and S3I). No change in the pas-
sive diameter of the renal arteries was observed in the absence
of extracellular calcium together with SNP and papaverine
(Figure S3J).
Decreased active resistance of the renal circulation in the
absence of smFlnA is anticipated to lower glomerular transca-
pillary hydraulic pressure. Accordingly, we observed a potent
protection against Ang-II-induced proteinuria in the smFlnA0/
mice (Figure S3C), although the hypertensive effect of Ang II
infusion was comparable between both mouse lines (Figures
S1C–S1F).
Thus, smFlnA has a major influence on the basal active resis-
tance of the renal circulation and thereby impacts on glomer-
ular filtration. Next, we investigated whether pressure-depen-
dent calcium signaling might be altered in the absence of
smFlnA.
Pressure-Dependent Calcium Signaling Is Impaired in
the Absence of smFlnA
Using ratiometric Fura-2 calcium imaging in isolated pressurized
caudal arteries, we monitored a rapid and reversible rise in intra-
cellular calcium occurring in a pressure-dependent manner (Fig-
ure 3A). When nifedipine was added to inhibit CaV1.2 calcium
channels, this pressure-dependent calcium signal was greatly
blunted (Figure 3B). Our recent work has demonstrated that
the stretch-activated cationic channel Piezo1 is dispensable
for the myogenic tone of both caudal and cerebral arteries (Re-
tailleau et al., 2015). In linewith these findings, smPiezo1 deletion
did not alter pressure-dependent calcium signaling in the caudal
artery (Figure 3B; gray circles). When extracellular calcium was
omitted the increase in intracellular calcium was fully sup-
pressed, further demonstrating that a calcium influx is at play
(Figure 3B). Upon deletion of smFlnA, a rise in basal cytosolicll Reports 14, 2050–2058, March 8, 2016 ª2016 The Authors 2053
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Figure 3. Pressure-Dependent Calcium Influx in Arterial Myocytes
Critically Requires smFlnA
(A) Intracellular calcium was monitored using Fura-2 ratiometric fluorescence
calcium imaging on a pressurized whole caudal artery (intraluminal stop flow).
The artery (smFlnA0/+ Piezo1+/+ at 12 weeks post-TAM induction) was initially
bathed in a control saline solution containing extracellular calcium (1.6 mM)
and challenged with 80 mM KCl at an intra-luminal pressure of 75 mm Hg or
with 1 mM phenylephrine (see Figure S4). After a period of stabilization at
75 mm Hg, intraluminal pressure was gradually increased from 10 to 100 mm
Hg. Between each pressure step, pressure was stepped back to 10 mm Hg.
(B) Calcium transient (D; as indicated in A) induced by the increase in pressure
(the basal signal at 10 mm Hg has been subtracted for each pressure step) in
the presence of extracellular calcium (1.6 mM). Subsequently, 3 mM nifedipine
was added to inhibit L-type calcium channels. Finally, extracellular calcium
was omitted together with added 500 mM EGTA, before calibration. Control
mice (smFlnA0/+ Piezo1+/+) are indicated by white circles. smFlnA was deleted
alone (smFlnA0/ Piezo1+/+; black circles) or together with Piezo1 (smFlnA0/
Piezo1/; red circles). In addition, Piezo1 was deleted alone (smFlnA0/+
Piezo1/; gray circles). The number of arteries (n) is indicated.
Data are shown as means ± SEM.calcium was observed at 10 mm Hg (Figure S4A; black circles).
Deletion of smPiezo1 together with FlnA prevented this basal in-
crease in intracellular calcium (Figure S4A, red circles). Remark-
ably, the pressure-dependent calcium influx (D) was dramatically2054 Cell Reports 14, 2050–2058, March 8, 2016 ª2016 The Authorsreduced upon smFlnA deletion, with or without Piezo1 (Figures
3B and S4A; black and red circles). On the contrary, a large cal-
cium transient could still be induced by cell depolarization
(80 mM KCl at 75 mm Hg) or by PE addition (at 75 mm Hg) in
the absence of smFlnA (Figure S4A). Moreover, whole-cell
patch-clamp recordings indicated that both voltage-dependent
calcium and potassium channels were unaltered upon smFlnA
deletion (Figures S4B–S4G). Of note, the impairment of both
myogenic tone and vasomotion of the caudal artery in the
absence of smFlnA was independent of Piezo1 (Figures S4H
and S4I).
These findings indicate that smooth muscle L-type calcium
channels (CaV1.2) are functional in the absence of FlnA, although
they fail to open in response to an increase in intraluminal pres-
sure. In line with these results, next we investigated whether
CaV1.2 might be directly mechanosensitive.
Stretch Activation of CaV1.2 Is Modulated by smFlnA
Exogenous CaV1.2 was transfected in M2 melanoma cells ex-
pressing FlnA, as well as native FlnB (Cunningham et al., 1992;
Sverdlov et al., 2009) (Figures 4 and S4J–S4M). Mock-trans-
fected M2 cells lack native voltage-gated calcium channels
(Figures 4A, 4C, and S4J). Upon co-transfection of the a1C,
a2d1, b1, and b2 CaV1.2 subunits, we recorded depolariza-
tion-activated inward barium currents in the cell-attached patch
configuration (Figure 4B). During a maintained membrane de-
polarization to 20 mV (near the predicted reversal potential
of non-selective SACs), we applied pulses of pressure of
increasing amplitude (Figures 4A and 4B). In EGFP-transfected
cells, no channel activity was seen, while stretch-induced in-
ward currents were consistently elicited in the CaV1.2 express-
ing cells (n = 6; Figure 4B). A reversible enhancement of a1C
alone by a steady pressure stimulation of 35 mm Hg was
also observed at 0 mV, despite lower current amplitude in the
absence of regulatory subunits (Figures 4C and 4D). Next, we
analyzed in more detail the mechanism of CaV1.2 modulation
by membrane stretch (Figures S4J–S4M). Mild steady pressure
stimulation (35 mm Hg), allowing the construction of I-V
curves without patch disruption, reversibly shifted the activa-
tion curve by about 10 mV toward more negative membrane
potentials (Figures S4K–S4M). This negative shift of activation
resulted in about a 2-fold increase in current amplitude at nega-
tive membrane potentials (Figures S4K–S4M). By contrast,
voltage-dependent inactivation was not altered by membrane
stretch (Figure S4L, inset). These findings, along with previous
observations demonstrating shear stress stimulation of a1C
(Lyford et al., 2002), indicate that CaV1.2 is sensitive to me-
chanical stress.
Next, we recorded native CaV1.2 channels in arterial myo-
cytes using the same patch configuration (Figures 4E–4G).
We used isolated caudal artery myocytes from smPiezo1/
mice, to avoid the contribution of non-selective SACs (Retail-
leau et al., 2015). Depolarization to 0 mV elicited small inward
barium currents (black trace, Figure 4E). When the patch was
mechanically stimulated by a steady pressure of 35 mm Hg,
the amplitude of the inward current was reversibly
enhanced (red and blue traces, Figure 4E). In the range
of the resting membrane potential of arterial myocytes
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E Figure 4. Upregulation of CaV1.2 by Mem-
brane Stretch Is Influenced by FlnA
(A) EGFP-transfected M2 cell. The voltage proto-
col is shown on top, the current trace in themiddle,
and the pressure protocol (color coded) in the
bottom.
(B) a1C+a2d1+b1b+b2-transfected M2 cell. Same
voltage and pressure protocols as (A).
(C) EGFP-transfected M2 cell. The voltage proto-
col is shown on top, the current trace is shown at
the bottom. This patch has been recorded at 0 mm
Hg (black trace), 35 mm Hg (red trace), and back
to 0 mm Hg (blue trace).
(D) a1C+a2d1+b1b+b2-transfected M2 cell. Same
protocol as (C).
(E) Native L-type (CaV1.2) calcium channel cur-
rents in a caudal artery myocyte from a
smPiezo1/mouse recorded in the cell-attached
patch configuration under membrane stretch. The
voltage protocol is shown on top and the current
traces are below. Currents have been recorded at
0 mmHg (black trace),35mmHg (red trace), and
back to 0 mm Hg (blue trace). The extrapolated
leak current at 0 mV is shown by a dotted line.
(F) Stretch activation of native L-type calcium
channels at a membrane potential of 30 mV in a
myocyte from a Piezo1/mouse, recorded in the
cell-attached patch configuration. The extrapo-
lated leak current at 30 mV is shown by a dotted
line. The voltage protocol is shown on top, the
current trace is in the middle, and the pressure
protocol is at the bottom.
(G) Pressure-effect curve of the endogenous in-
ward currents recorded at a membrane potential
of 30 mV for caudal artery myocytes from
smFlnA0/+ Piezo1/ and smFlnA0/ Piezo1/
mice. Numbers of patches are indicated in the
legend.
Data are shown as means ± SEM.(between 40 and 30 mV), inward currents could be revers-
ibly elicited upon pressure stimulation (Figures 4E–4G).
Notably, the pressure-effect curve of CaV1.2 (in the Piezo1/
background) was shifted toward more negative pressure
upon smFlnA deletion (Figure 4G).
Finally, we explored the eventual contribution of mechano-
sensitive K+ channels in caudal artery myocytes. Previous find-
ings suggested a possible role for stretch-inactivated K+ chan-
nels in the initiation of the mesenteric artery myogenic response
(Schleifenbaum et al., 2014). In caudal artery smooth muscle
cells from both smFlnA0/+ Piezo1/ (n = 37) and smFlnA0/
Piezo1/ (n = 41) mice, we found no significant effect of stretch
(50 mm Hg) on potassium currents over the whole voltage
range, when recorded in the cell-attached patch configuration
(data not shown; E.H. unpublished data).Cell Reports 14, 2050–205DISCUSSION
Our findings indicate that specific dele-
tion of smFlnA in adult mice dramatically
impairs the arterial myogenic tone of
both the caudal and renal arteries, whilereactivity to vasoconstrictors is preserved. Notably, smFlnA is
critically required for pressure-dependent calcium influx through
CaV1.2 in arterial myocytes. Thus, these findings place smFlnA
as an upstream element in the mechanotransduction signaling
cascade responsible for the myogenic activation of arterial
myocytes.
Our recent findings rule out a role for the cationic non-selective
stretch-activated channels (SACs) in the myogenic response of
both resistance and cerebral arteries (Retailleau et al., 2015).
Indeed, Piezo1 is fully dispensable for the myogenic response
but is critically required for SAC activity in arterial myocytes (Re-
tailleau et al., 2015). Similarly, the cationic channel TRPC6 is
dispensable for the arterial myogenic tone (Schleifenbaum
et al., 2014). Alternatively, recent results suggest that inhibition
of smooth muscle voltage-dependent K+ channels (sensitive to8, March 8, 2016 ª2016 The Authors 2055
the KCNQ blocker XE991, but different from KCNQ3, 4, or 5)
might contribute to mesenteric artery smooth muscle cell depo-
larization at elevated intraluminal pressure, resulting in the sec-
ondary opening of the voltage-dependent CaV1.2 channels
(Moosmang et al., 2003; Schleifenbaum et al., 2014). A mechan-
ical agonism of the Ang II type 1 receptor (AT1R), independently
of Ang II, has been implicated in both the pressure-dependent in-
hibition of smooth muscle cell K+ channels and the arterial
myogenic response of both mesenteric and renal arteries
(Blodow et al., 2014;Mederos y Schnitzler et al., 2008; Schleifen-
baum et al., 2014). Whether FlnA might be involved in the
mechanical agonism of AT1Rs (although we found no effect of
losartan on the myogenic tone of the caudal artery) and/or
required for the downstream modulation of K+ channels is an
intriguing possibility. However, in the present study, we found
no evidence for stretch-inactivated K+ channels in caudal artery
myocytes, suggesting that an alternative mechanismmight be at
play in this arterial bed.
We observed a stretch sensitivity of CaV1.2 (a1C), in agree-
ment with a previous report demonstrating shear stress stimula-
tion of a human intestinal a1C isoform (Lyford et al., 2002). The
stimulation of Cav1.2 opening by membrane stretch in the
voltage range of the resting membrane potential of arterial myo-
cytes occurs independently of Piezo1 but is significantly influ-
enced by smFlnA. Without FlnA, the pressure-effect curve of
CaV1.2 was shifted toward more negative pressure, resulting
in a blunted calcium influx in response to an increased intralumi-
nal pressure. How can smFlnA influence CaV1.2 opening in
response to pressure? Channel density and voltage-dependent
gating in the absence of mechanical stimulation were not altered
by smFlnA deletion (Figures S4B–S4G). Moreover, intrinsic
CaV1.2 mechanosensitivity, although shifted toward higher
pressure values, was still operating in the absence of smFlnA
(Figure 4G). Thus, one possible defect in the absence of smFlnA
might be altered force transmission to the CaV1.2 complex.
Interestingly, the actin binding protein FlnA also interacts
through its C-terminal domain with a variety of transmembrane
proteins and thereby physically links the actin cytoskeleton to
the plasma membrane (Nakamura et al., 2011; Razinia et al.,
2012; Zhou et al., 2007). An important membrane partner of
FlnA is caveolin-1 (Echarri and Del Pozo, 2015; Muriel et al.,
2011; Stahlhut and van Deurs, 2000; Sverdlov et al., 2009).
FlnA anchors caveolae to actin stress fibers by interacting
with caveolin 1 (Echarri and Del Pozo, 2015). Caveolae are
cholesterol-rich membrane invaginations highly abundant in me-
chanically stressed cells (Echarri and Del Pozo, 2015), including
arterial smooth muscle cells of the caudal artery (data not
shown). Notably, cholesterol sequestration or caveolin-1/
cavin-1 deletion impairs pressure-dependent calcium influx
and the arterial myogenic response, thus mimicking the effect
of smFlnA deletion (Adebiyi et al., 2007; Balijepalli et al., 2006;
Drab et al., 2001; Dubroca et al., 2007; Swa¨rd et al., 2014).
Interestingly, previous findings have demonstrated an interac-
tion between caveolin-1 and the C-terminal domain of a1C,
with a localization of CaV1.2 in caveolae of mesenteric artery
smooth muscle cells (Suzuki et al., 2013). Altogether, these find-
ings could be consistent with a possible role for FlnA in force
transmission to the pool of CaV1.2 channels located within cav-2056 Cell Reports 14, 2050–2058, March 8, 2016 ª2016 The Authorseolae. Without smFlnA, caveolae would buffer membrane ten-
sion resulting in a blunted modulation of CaV1.2 by force (Sinha
et al., 2011). The definitive demonstration of this attractive hy-
pothesis will need to await the availability of highly resolutive
and quantitative molecular tools allowing the measurement of
membrane tension specifically within caveolae of arterial
myocytes.
In conclusion, the cytoskeleton element smFlnA plays a key
role in the arterial myogenic tone. Our data indicate that smFlnA
is critically required for the pressure-dependent calcium influx
through CaV1.2 initiating the myogenic response and vasomo-
tion (Moosmang et al., 2003; Schleifenbaum et al., 2014). By
contrast, smFlnA negatively regulates the opening of Piezo1
that influences arterial remodeling through activation of transglu-
taminases (Retailleau et al., 2015). Altogether, our findings
demonstrate that the actin cytoskeleton network acts in concert
with calcium channels at the plasma membrane of arterial
smooth muscle cells to sense changes in intraluminal pressure.
Not only do these results provide information about the molecu-
lar basis of the arterial myogenic tone, they also suggest a more
general role for voltage-gated calcium channels in cellular me-
chanotransduction. The function for CaV1.2, and possibly for
other CaV isoforms, as force-gated ion channels will need to
be further investigated in the context of mechanosensory trans-
duction, mechanical nociception, and baroreceptor reflex con-
trol of blood pressure. In summary, our study indicates that
CaV1.2 acts in parallel with Piezo1 in arterial myocytes as
mechanosensors responsible for pressure-dependent autoregu-
lation (the present report) and hypertension-dependent remodel-
ing (Retailleau et al., 2015), respectively. Finally, the present
results will also contribute to a better understanding of the
vascular phenotype of PH patients.EXPERIMENTAL PROCEDURES
Mice
Experiments were carried out in accordance with the guidelines of the Institu-
tional Ethical Committee for Experimental Animals and conform to the Guide
for the Care and Use of Laboratory Animals (NIH Publication no. 85-23, revised
1996). The study was approved by the local Committee for ethical and safety
issues (CIEPAL-Azur). The procedure followed in the care and euthanasia of
the study animals was in accordancewith the European Community standards
on the care and use of laboratory animals.
TAM-inducible smMHCCre* male mice (inducible Cre* is inserted in the
Y chromosome [Wirth et al., 2008]) were crossed with female FlnAlox/lox mice
to achieve a smooth-muscle-specific deletion of FlnA at the adult stage
(smMHCCre* FlnA0/), thus avoiding developmental effects of the knockout
(Feng et al., 2006). Of note, male mice are hemizygotes for FlnA as the gene
is on the X chromosome (FlnA0/+). Mice were backcrossed at least 12 times
onto a C57BL/6 background. Twelve-week-old adult male mice were injected
twice intra-peritoneally with TAM (50 mg/kg/day dissolved in peanut oil, EtOH
10%). Mice were studied within 12 weeks after TAM injection. In the control
group, we included FlnA0/lox and smMHCCre* mice injected with TAM, and,
since no significant difference was observed between both genotypes, data
were merged (smFlnA0/+). smPiezo1/ mouse lines have been previously
described (Retailleau et al., 2015).
Statistics
Significance of the differences was tested with a permutation test (R Develop-
ment Core Team: http://www.r-project.org/) (n < 30) or two samples t test
(n > 30). One star indicates p < 0.05, two stars p < 0.01, and three stars
p < 0.001. Data represent mean ± SEM. N indicates the number of mice stud-
ied. n indicates the number of cells or arteries.
A detailed materials and methods section is available in the Supplemental
Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.02.019.
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